Studies on the retention of passively transferred antibodies in man. II. Antibody activity in the blood after intravenous or intramuscular administration of anti-HBs human immunoglobulin
- PMID: 6880149
- DOI: 10.1111/j.1423-0410.1983.tb04126.x
Studies on the retention of passively transferred antibodies in man. II. Antibody activity in the blood after intravenous or intramuscular administration of anti-HBs human immunoglobulin
Abstract
Catabolism of intravenously or intramuscularly administered human immunoglobulin in man was studied by the administration of HBs antibodies at a high titer and analysis with a highly sensitive radioimmunoassay technique. The half-life in the blood of the antibodies in the aggregate-reduced antibody preparation administered intravenously was found to be 17.7 days and of those in the antibody preparation administered intramuscularly to be 23.8 days.
Similar articles
-
Studies on the retention of passively transferred antibodies in man. I. Quantitative measurement of the antibody activities to HBs by radioimmunoassay and its application to studies on the blood level of intravenously administered 7 S or 5 S antibody.Vox Sang. 1982;43(4):205-11. doi: 10.1111/j.1423-0410.1982.tb00013.x. Vox Sang. 1982. PMID: 7135888
-
Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation.Transplantation. 1997 Feb 15;63(3):478-80. doi: 10.1097/00007890-199702150-00027. Transplantation. 1997. PMID: 9039945 Clinical Trial.
-
[Uptake and elimination of hepatitis B immunoglobulin after intramuscular administration].Dtsch Med Wochenschr. 1982 Dec 17;107(50):1918-22. doi: 10.1055/s-2008-1070233. Dtsch Med Wochenschr. 1982. PMID: 7140575 German.
-
Intravenous immunoglobulin: a review.Immunodefic Rev. 1989;1 Suppl:1-42. Immunodefic Rev. 1989. PMID: 2698646 Review.
-
Intravenous immune globulin therapy in hypogammaglobulinemia. A review.Am J Med. 1984 Mar 30;76(3A):53-60. doi: 10.1016/0002-9343(84)90320-6. Am J Med. 1984. PMID: 6424457 Review.
Cited by
-
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.Hum Vaccin Immunother. 2022 Apr 29;18(2):1886560. doi: 10.1080/21645515.2021.1886560. Epub 2021 May 19. Hum Vaccin Immunother. 2022. PMID: 34010089 Free PMC article. Review.
-
Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation.Eur J Clin Pharmacol. 1995;49(3):237-42. doi: 10.1007/BF00192385. Eur J Clin Pharmacol. 1995. PMID: 8666001
MeSH terms
Substances
LinkOut - more resources
Full Text Sources